HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedNCT03044249

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Medication studyAges 50+Canada + United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: from 50 years.

Listed locations
Phoenix and 19 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 4, 2017
Recruitment status
Terminated
Enrollment listed in the registry
81
Sponsor
Mediti Pharma Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada
Age range
Over 50 Years
Official registry ID
NCT03044249
Official title
Show the full official title

Tolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Patients With Dementia-Related Psychosis and/or Agitation and Aggression

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Terminated

Phoenix, United States · Pasadena, United States · Fairfield, United States

17 more locations
  • Boca Raton, United States
  • Brooksville, United States
  • Hialeah, United States
  • Miami Springs, United States
  • Orlando, United States
  • Port Charlotte, United States
  • St. Petersburg, United States
  • Tampa, United States
  • Overland Park, United States
  • Shreveport, United States
  • Paterson, United States
  • East Syracuse, United States
  • Staten Island, United States
  • Dayton, United States
  • Newmarket, Canada
  • Montreal, Canada
  • Sherbrooke, Canada
Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mediti Pharma Inc., a pharmaceutical company.

Does this study involve medication?

Yes. The study involves medication, including MP-101 and Placebo.

Who can participate?

Listed age limits: from 50 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies